Marshall Wace
IMA

Marshall Wace’s ImageneBio Inc IMA Stock Holding History

Marshall Wace’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,744
Closed -$74.1K – 2713
2024
Q2 		$74.1K Sell
3,744
-3,647
-49% -$64.4K ﹤0.01% 2417
2024
Q1 		$126K Buy
+7,391
New +$135K ﹤0.01% 2286

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

Marshall Wace's IMA Position: Q3 2024 in Review

Marshall Wace sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 3,744 shares — an estimated $74.1K sold.

Marshall Wace first reported a position in IMA in Q1 2024 and held it in 2 quarters. The position peaked at $126K in Q1 2024. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

  • Marshall Wace reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 3,744 ImageneBio Inc shares in Q3 2024, an estimated $74.1K.
  • Marshall Wace first reported a position in ImageneBio Inc in Q1 2024 and held it in 2 quarters.
  • Marshall Wace's ImageneBio Inc position peaked at $126K in Q1 2024.
  • 57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.